ArticleFrontiers in oncology2021

Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma.

Lei She et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.